Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "leucine rich repeat containing 40 pseudogene" is a DNA segment resembling the functional *leucine rich repeat containing 40* (LRRC40) gene, but with mutations such as frameshifts or premature stop codons that prevent production of a functional protein[4][6]. Pseudogenes arise either by gene duplication/retrotransposition or by disabling mutations in a previously functional gene[2][6]. In humans, pseudogenes are prevalent and may complicate genome annotation and genetic analysis, but most do not have direct functional or therapeutic relevance[6]. For context, the **LRRC40 gene** (distinct from the pseudogene) encodes a protein believed to participate in protein-protein interactions, contains leucine-rich repeats, and is conserved across many species[1]. However, the pseudogene variant is nonfunctional and does not produce protein; any biological effects would be through RNA interactions, which are not well-characterized for this locus[2][6]. If you are seeking information about a *therapeutic target*, you should refer to the functional **LRRC40 protein** and not the pseudogene. The presence of "pseudogene" in the canonical designation is a clear indication of nonfunctionality in classical molecular biology and drug targeting contexts[4][6].
Not applicable. No mechanistically-targeted drugs or interventions exist for this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine rich repeat containing 40 pseudogene (None established; often referenced by the Ensembl identifier (ENSG00000270421) or as "LRRC40 pseudogene.").